ClinicalTrials.Veeva

Menu
H

Hospital Italiano de Cordoba | Pneumonology Service

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Macitentan
JNJ-53718678
Tocilizumab
Apixaban
Treprostinil
Ustekinumab
Ralinepag
Baricitinib
Ambrisentan
ART-123

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) st...

Enrolling
Hypertension
Familial Primary Pulmonary Hypertension
Drug: Ralinepag
Drug: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

Trial sponsors

Janssen (J&J Innovative Medicine) logo
United Therapeutics logo
Actelion Pharmaceuticals logo
A
Gilead Sciences logo
Lilly logo
N
Otsuka logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems